In 2006, Gigi Quiroz was the first-ever patient to receive ophthalmic artery chemosurgery (OAC) to treat retinoblastoma, a pediatric eye cancer. As a result, she was able to maintain vision in both eyes, which was practically unheard of at the time. When the Chief of MSK’s Ophthalmic Oncology Service, David Abramson, saw how quickly and efficiently OAC got rid of Gigi’s cancer, he knew he had a life-changing treatment on his hands. Thanks to Gigi, the vast majority of MSK patients with retinoblastoma now receive OAC — and get to keep their eyesight.
Daniel was an otherwise healthy toddler until he suddenly started spitting out his food at meals, having recurrent fevers, and experiencing sore knees. He endured months of misdiagnosis before doctors identified advanced neuroblastoma, a rare cancer of the nerve tissue. At Memorial Sloan Kettering, he received an innovative therapy that activated his immune system to fight the cancer.